drug · small molecule
JBI-802
Phase 2updated 3mo agoby Jubilant Therapeutics Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
indications
indications
Prostate Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying JBI-802
- phase2Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis
- phase2A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 43m ago
Found something off?
comments(0)
5-min edit window · permanent after that